question_key
stringlengths 16
58
| relation
stringlengths 6
48
| question_template
stringlengths 29
90
| subject_cui
stringlengths 8
8
| subject_label
stringlengths 4
160
| correct_object_cui
stringlengths 8
8
| correct_object_label
stringlengths 3
204
| opa
stringlengths 7
150
| opb
stringlengths 3
204
| opc
stringlengths 4
221
| opd
stringlengths 5
166
| cop
int64 0
3
|
|---|---|---|---|---|---|---|---|---|---|---|---|
C1515261::has_gene_product_element
|
has_gene_product_element
|
Which gene product is an element of the pathway {subj}?
|
C1515261
|
Telomere Pathway
|
C1333229
|
POLR2A protein, human
|
SAR1B protein, human
|
POLR2A protein, human
|
PRRT2 protein, human
|
RSAD2 protein, human
| 1 |
C2265640::has_gene_product_element
|
has_gene_product_element
|
Which gene product is an element of the pathway {subj}?
|
C2265640
|
Autophagy Regulation Pathway
|
C0967698
|
RRAGC protein, human
|
RETN protein, human
|
DNER protein, human
|
NRBP protein, human
|
RRAGC protein, human
| 3 |
C1877749::has_ingredient
|
has_ingredient
|
Which of the following is an ingredient of {subj}?
|
C1877749
|
{21 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack
|
C0068992
|
norgestimate
|
Norgestomet only product
|
norgestimate
|
norgestrel and estrogen
|
Norgestimate only product
| 1 |
C2955132::has_ingredient
|
has_ingredient
|
Which of the following is an ingredient of {subj}?
|
C2955132
|
Duet DHA Balanced, Prenatal Multivitamins with Folic Acid 1 mg oral kit
|
C0008318
|
cholecalciferol
|
cholecalciferol / glucosamine
|
cholecalciferol / chromium picolinate
|
cholecalciferol
|
cholecalciferol / levomefolate
| 2 |
C1962428::has_ingredient
|
has_ingredient
|
Which of the following is an ingredient of {subj}?
|
C1962428
|
{21 (ethinyl estradiol 0.05 MG / ethynodiol diacetate 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Zovia 1/50E 28 Day]
|
C0015011
|
ethinyl estradiol
|
chlormadinone / ethinyl estradiol
|
ethinyl estradiol
|
chlormadinone and ethinylestradiol
|
algestone / estradiol
| 1 |
C5852768::has_inherent_location
|
has_inherent_location
|
What is the inherent location of {subj}?
|
C5852768
|
Laterality of primary malignant neoplasm of oral soft tissue
|
C0447424
|
Oral soft tissues
|
Orbital Ridge
|
Oral soft tissues
|
Hard tissue of tooth
|
Structure of soft tissues of buttock
| 1 |
C5852686::has_inherent_location
|
has_inherent_location
|
What is the inherent location of {subj}?
|
C5852686
|
Histologic grade of primary malignant neoplasm of cecum and/or colon and/or rectum
|
C5848823
|
Structure of cecum and/or colon and/or rectum
|
Structure of pelvic aspect of sacrum
|
Structure of cecum and/or colon and/or rectum
|
Structure of mesenteric border of jejunum
|
Structure of posterior margin of nasal septum and/or choana
| 1 |
C5852596::has_inherent_location
|
has_inherent_location
|
What is the inherent location of {subj}?
|
C5852596
|
Surgical margin closest to noninvasive premalignant neoplasm in excised pharynx specimen
|
C0031354
|
Pharyngeal structure
|
Hyponychium of ring finger
|
Pharyngeal hypophysis
|
Pharyngeal structure
|
Stapedial membrane
| 2 |
C1843355::has_inheritance_type
|
has_inheritance_type
|
What is the inheritance type of {subj}?
|
C1843355
|
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS
|
C0441748
|
Autosomal recessive inheritance
|
somatic recombination of T cell receptor gene segments
|
Genetic independent segregation
|
Autosomal recessive inheritance
|
Allelic exclusion
| 2 |
C5779972::has_inheritance_type
|
has_inheritance_type
|
What is the inheritance type of {subj}?
|
C5779972
|
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 1
|
C0441748
|
Autosomal recessive inheritance
|
Autosomal recessive inheritance
|
meiotic DNA recombinase assembly involved in meiotic gene conversion
|
Genetic independent segregation
|
Recombination, Genetic
| 0 |
C5830291::has_inheritance_type
|
has_inheritance_type
|
What is the inheritance type of {subj}?
|
C5830291
|
CARDIOMYOPATHY, DILATED, 1OO
|
C0443147
|
Autosomal dominant inheritance
|
Autosomal dominant inheritance
|
Nondisjunction, Genetic
|
Allelic exclusion
|
Recombination, Genetic
| 0 |
C2091838::has_intent
|
has_intent
|
What is the intent of {subj}?
|
C2091838
|
Prophylactic pinning of femoral neck and proximal femur
|
C0199176
|
Prophylactic treatment
|
Prophylactic treatment
|
Prophylactic wrist stretching
|
Prophylactic knee stretching
|
Prophylactic hip stretching
| 0 |
C2945703::has_intent
|
has_intent
|
What is the intent of {subj}?
|
C2945703
|
Prophylactic oophorectomy
|
C0199176
|
Prophylactic treatment
|
Prophylaxis of abortion
|
Prophylactic treatment
|
Administration of prophylactic treatment
|
Prophylactic wrist stretching
| 1 |
C2191320::has_intent
|
has_intent
|
What is the intent of {subj}?
|
C2191320
|
Prophylactic Mastectomy
|
C0199176
|
Prophylactic treatment
|
Prophylactic ankle stretching
|
Prophylactic shoulder stretching
|
Prophylactic treatment
|
Administration of prophylactic treatment
| 2 |
C1183575::has_lymphatic_drainage
|
has_lymphatic_drainage
|
What is the lymphatic drainage of {subj}?
|
C1183575
|
Superficial fascia of right breast proper
|
C2328170
|
Cutaneous lymphatic tree of right breast proper
|
Structure of lymphatic vessel of right foot
|
Structure of lymphatic vessel of right axilla
|
Cutaneous lymphatic tree of right breast proper
|
Trunk of right lower lobe lymphatic tree
| 2 |
C0230329::has_lymphatic_drainage
|
has_lymphatic_drainage
|
What is the lymphatic drainage of {subj}?
|
C0230329
|
Right upper extremity
|
C0933321
|
Right subclavian lymphatic tree
|
Left lower intercostal lymphatic vessel
|
Right apical axillary lymphatic vessel
|
Right jugular lymphatic tree
|
Right subclavian lymphatic tree
| 3 |
C0929543::has_lymphatic_drainage
|
has_lymphatic_drainage
|
What is the lymphatic drainage of {subj}?
|
C0929543
|
Central area of central tendon
|
C2328358
|
Lateral diaphragmatic lymphatic chain
|
Lymphatic chain of lateral segmental bronchus
|
Right lower intercostal lymphatic vessel
|
Entire lateral pericardial lymph node
|
Lateral diaphragmatic lymphatic chain
| 3 |
C4749028::has_manifestation
|
has_manifestation
|
What is a manifestation of {subj}?
|
C4749028
|
CILIARY DYSKINESIA, PRIMARY, 40
|
C0035455
|
Rhinitis
|
Obstructive rhinitis
|
Other allergic rhinitis
|
Rhinitis
|
Ulcerative rhinitis
| 2 |
C5774243::has_manifestation
|
has_manifestation
|
What is a manifestation of {subj}?
|
C5774243
|
CLEIDOCRANIAL DYSPLASIA 2
|
C0018784
|
Sensorineural Hearing Loss (disorder)
|
Sudden sensorineural hearing loss
|
Sensorineural Hearing Loss (disorder)
|
Congenital mixed conductive and sensorineural hearing loss
|
Maternal perinatal sensorineural hearing loss
| 1 |
C2751535::has_manifestation
|
has_manifestation
|
What is a manifestation of {subj}?
|
C2751535
|
Prostaglandin-Endoperoxide Synthase 1 Deficiency, Platelet
|
C0025323
|
Menorrhagia
|
Hemorrhagic vaginal discharge
|
Premenopausal menorrhagia
|
Menorrhagia
|
Hemorrhagic inflammation
| 2 |
C0770891::has_mechanism_of_action
|
has_mechanism_of_action
|
What is the mechanism of action of {subj}?
|
C0770891
|
flupentixol hydrochloride
|
C2757008
|
Dopamine Antagonists [MoA]
|
Decreased Serotonin Degradation
|
negative regulation of L-dopa decarboxylase activity
|
Dopamine Antagonists [MoA]
|
tryptamine 4-monooxygenase activity
| 2 |
C0060501::has_mechanism_of_action
|
has_mechanism_of_action
|
What is the mechanism of action of {subj}?
|
C0060501
|
flunisolide
|
C1373068
|
Glucocorticoid Receptor Agonists
|
Cytokine Receptor Activation
|
Pituitary Hormone Receptor Binding
|
Glucocorticoid Receptor Agonists
|
glucocorticoid biosynthetic process
| 2 |
C0031978::has_mechanism_of_action
|
has_mechanism_of_action
|
What is the mechanism of action of {subj}?
|
C0031978
|
pirenzepine
|
C1373102
|
Cholinergic Muscarinic Antagonists [MoA]
|
Increased Acetylcholine Activity
|
Increased Sensory-Somatic Nervous System Substance P Activity
|
Cholinergic Muscarinic Antagonists [MoA]
|
Serotonin Receptor Binding
| 2 |
C0927199::has_member
|
has_member
|
Which of the following is a member of {subj}?
|
C0927199
|
Musculature of mouth
|
C0921226
|
Left levator anguli oris
|
Left levator anguli oris
|
Third levator costae muscle
|
Left torus levatorius
|
Nerve to left depressor anguli oris
| 0 |
C2335931::has_member
|
has_member
|
Which of the following is a member of {subj}?
|
C2335931
|
Lymph node group of left axilla
|
C2328374
|
Left pectoral lymph node
|
Entire pectoral axillary lymph node
|
Left pectoral lymph node
|
Left pectoral axillary lymphatic chain
|
Superior mediastinal lymph node
| 1 |
C0833291::has_member
|
has_member
|
Which of the following is a member of {subj}?
|
C0833291
|
Set of thenar muscles
|
C0224288
|
Adductor pollicis muscle structure
|
Structure of right abductor pollicis longus tendon sheath
|
Entire extensor pollicis longus muscle tendon sheath
|
Adductor pollicis muscle structure
|
Head of adductor pollicis muscle
| 2 |
C0025853::has_modification
|
has_modification
|
What modification does {subj} have?
|
C0025853
|
metoclopramide
|
C0887128
|
metoclopramide hydrochloride
|
metoclopramide hydrochloride
|
ractopamine hydrochloride
|
trifluperidol hydrochloride
|
bupranolol hydrochloride
| 0 |
C0053225::has_modification
|
has_modification
|
What modification does {subj} have?
|
C0053225
|
benzoic acid
|
C0142805
|
sodium benzoate
|
sodium benzoate
|
sodium propionate
|
benzocaine / zinc oxide
|
sodium succinate
| 0 |
C0022060::has_modification
|
has_modification
|
What modification does {subj} have?
|
C0022060
|
Ipronidazole
|
C0521905
|
Ipronidazole hydrochloride
|
levomilnacipran hydrochloride
|
benactyzine hydrochloride + meprobamate
|
Ipronidazole hydrochloride
|
phendimetrazine hydrochloride
| 2 |
C0038351::has_nerve_supply
|
has_nerve_supply
|
What is the nerve supply of {subj}?
|
C0038351
|
Stomach
|
C2330104
|
Left phrenic nerve plexus
|
Left second superior phrenic artery
|
Left phrenic nerve plexus
|
Right inferior phrenic artery
|
Diaphragmatic branch of left phrenic nerve
| 1 |
C0224384::has_nerve_supply
|
has_nerve_supply
|
What is the nerve supply of {subj}?
|
C0224384
|
Structure of levator ani muscle
|
C0228960
|
Structure of hemorrhoidal nerve
|
Structure of hyaloid artery
|
Entire hemorrhoidal nerve
|
Structure of genicular artery
|
Structure of hemorrhoidal nerve
| 3 |
C0224349::has_nerve_supply
|
has_nerve_supply
|
What is the nerve supply of {subj}?
|
C0224349
|
Structure of serratus anterior muscle
|
C0228847
|
Structure of long thoracic nerve
|
Trunk of thoracic nerve
|
Structure of internal thoracic vein
|
Structure of long thoracic nerve
|
Structure of superior thoracic artery
| 2 |
C1325550::has_occurrence
|
has_occurrence
|
When does {subj} typically occur?
|
C1325550
|
chromatin location
|
C3158202
|
DNA-binding transcription factor activity, RNA polymerase II-specific
|
transcription antitermination factor activity, DNA binding
|
RNA polymerase III general transcription initiation factor activity
|
DNA-binding transcription factor activity, RNA polymerase II-specific
|
transcription antitermination factor activity, RNA binding
| 2 |
C0230789::has_occurrence
|
has_occurrence
|
When does {subj} typically occur?
|
C0230789
|
Smooth Endoplasmic Reticulum
|
C1656576
|
smooth endoplasmic reticulum calcium ion homeostasis
|
endoplasmic reticulum organization
|
regulation of translation in response to endoplasmic reticulum stress
|
endoplasmic reticulum tubular network organization
|
smooth endoplasmic reticulum calcium ion homeostasis
| 3 |
C0039062::has_occurrence
|
has_occurrence
|
When does {subj} typically occur?
|
C0039062
|
Synapses
|
C4236598
|
regulation of translation at synapse, modulating synaptic transmission
|
negative regulation of postsynaptic membrane organization
|
positive regulation of synapse assembly
|
positive regulation of synaptic vesicle membrane organization
|
regulation of translation at synapse, modulating synaptic transmission
| 3 |
C0734003::has_part
|
has_part
|
Which of the following is a part of {subj}?
|
C0734003
|
Wall of ileum
|
C0227317
|
Ileal mucous membrane
|
Ileal mucous membrane
|
Structure of left buccal mucosa
|
Mucosa of ureter proper
|
Vesical fundus part of vaginal artery
| 0 |
C3535926::has_part
|
has_part
|
Which of the following is a part of {subj}?
|
C3535926
|
alogliptin / metformin
|
C1958126
|
alogliptin
|
Digiglusin
|
ecallantide
|
alogliptin
|
soblidotin
| 2 |
C1278910::has_part
|
has_part
|
Which of the following is a part of {subj}?
|
C1278910
|
Entire oral cavity
|
C0447421
|
Midline of hard palate
|
Structure of right nasal-orbit bony complex
|
Medial surface of left auricular cartilage
|
Midline of hard palate
|
Right side of nasopharynx
| 2 |
C1290530::has_pathological_process
|
has_pathological_process
|
What pathological process is associated with {subj}?
|
C1290530
|
Lateral accessory root canals
|
C0586102
|
Pathological developmental process
|
Abnormal degeneration
|
Pathological fracture of ankle
|
Pathological developmental process
|
Chronic dilatation
| 2 |
C5190891::has_pathological_process
|
has_pathological_process
|
What pathological process is associated with {subj}?
|
C5190891
|
Hereditary isolated aplastic anemia
|
C4708780
|
Abnormal immune process
|
Abnormal Virilization
|
Abnormal immune process
|
Abnormal granulocyte production
|
Abnormal bladder function
| 1 |
C0015406::has_pathological_process
|
has_pathological_process
|
What pathological process is associated with {subj}?
|
C0015406
|
Eye Infections, Parasitic
|
C0745283
|
INFECTIOUS PROCESS
|
INFECTIOUS PROCESS
|
Hypothalamic dysfunction, NEC in SNOMEDCT
|
Neurogenic bowel, NEC in SNOMEDCT
|
Severe vaginal dysplasia, NEC in SNOMED CT
| 0 |
C3865296::has_pathology
|
has_pathology
|
What pathology is associated with {subj}?
|
C3865296
|
Quantitative carotid intima media thickness and carotid atheroma evaluation, bilateral
|
C0264956
|
Atheroma
|
Osteolysis
|
Atheroma
|
Hyperthecosis
|
Thrombosis
| 1 |
C2724268::has_pathology
|
has_pathology
|
What pathology is associated with {subj}?
|
C2724268
|
Aortic root translocation with ventricular septal defect and pulmonary stenosis repair (ie, Nikaidoh procedure); without coronary ostium reimplantation
|
C1261287
|
Stenosis
|
Venous stenosis
|
Stenosis of stoma
|
Secondary osteolysis
|
Stenosis
| 3 |
C0371182::has_pathology
|
has_pathology
|
What pathology is associated with {subj}?
|
C0371182
|
Repair, nonunion or malunion, femur, distal to head and neck; with iliac or other autogenous bone graft (includes obtaining graft)
|
C0158454
|
Malunited Fracture
|
Pathological fracture, unspecified humerus, subsequent encounter for fracture with malunion
|
Malunited Fracture
|
Pathological fracture, unspecified ulna and radius, subsequent encounter for fracture with malunion
|
Bipartite ossification
| 1 |
C0042849::has_permuted_term
|
has_permuted_term
|
What is a permuted term for {subj}?
|
C0042849
|
vitamin B complex
|
C3714647
|
Vitamin B Drug Class
|
Vitamin E Skin
|
Vitamin K5 only product
|
Vitaminoftalmina
|
Vitamin B Drug Class
| 3 |
C4226417::has_phenotype
|
has_phenotype
|
What phenotype is associated with {subj}?
|
C4226417
|
GFM2, IVS4DS, A-G, +4
|
C5193075
|
Combined oxidative phosphorylation defect type 39
|
Glycogen phosphorylase kinase deficiency, X-linked
|
Deficiency of phosphoribokinase
|
Combined oxidative phosphorylation defect type 39
|
Deficiency of phosphoglucomutase
| 2 |
C4746671::has_phenotype
|
has_phenotype
|
What phenotype is associated with {subj}?
|
C4746671
|
PMP2, ILE43ASN
|
C4748940
|
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1G
|
KERATODERMA, PALMOPLANTAR, PUNCTATE TYPE II
|
ENDOVE SYNDROME, LIMB-ONLY TYPE
|
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1G
|
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA
| 2 |
C5542422::has_phenotype
|
has_phenotype
|
What phenotype is associated with {subj}?
|
C5542422
|
SLCO2A1, IVS13, G-A, +1
|
C3280800
|
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2
|
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3
|
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2
|
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES
|
CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 2
| 1 |
C0018826::has_physical_part_of_anatomic_structure
|
has_physical_part_of_anatomic_structure
|
Which physical part of an anatomic structure does {subj} have?
|
C0018826
|
Heart Valves
|
C0225929
|
Anterior leaflet of tricuspid valve
|
Entire septal leaflet of tricuspid valve
|
Leaflet of mitral valve
|
Lunule of anterior cusp of aortic valve
|
Anterior leaflet of tricuspid valve
| 3 |
C0021853::has_physical_part_of_anatomic_structure
|
has_physical_part_of_anatomic_structure
|
Which physical part of an anatomic structure does {subj} have?
|
C0021853
|
Intestines
|
C1519375
|
Small Intestinal Wall Tissue
|
Large intestine or small intestine Tissue
|
Entire interstitial tissue of gastrointestinal tract
|
Tissue specimen from small intestine
|
Small Intestinal Wall Tissue
| 3 |
C0796361::has_physical_part_of_anatomic_structure
|
has_physical_part_of_anatomic_structure
|
Which physical part of an anatomic structure does {subj} have?
|
C0796361
|
Chromosome 7q
|
C1521643
|
7q21.2-q22.1
|
7q21.2-q22.1
|
Chromosomes, Human, 4-5
|
chromosome, centromeric region
|
polytene chromosome chromocenter
| 0 |
C0033230::has_physiologic_effect
|
has_physiologic_effect
|
What physiologic effect does {subj} have?
|
C0033230
|
prochlorperazine edisylate
|
C2267194
|
Decreased Central Nervous System Norepinephrine Activity
|
Decreased Central Nervous System Norepinephrine Activity
|
Negative Regulation of Degradation of Complement
|
central nervous system control of baroreceptor feedback
|
Negative Regulation of Degradation of Antibody
| 0 |
C0010137::has_physiologic_effect
|
has_physiologic_effect
|
What physiologic effect does {subj} have?
|
C0010137
|
cortisone
|
C1371294
|
Carbohydrate Metabolism Alteration [PE]
|
Carbohydrate Metabolism Alteration [PE]
|
trehalose transport in response to water deprivation
|
carbohydrate transmembrane transport
|
cell wall polysaccharide catabolic process
| 0 |
C0530105::has_physiologic_effect
|
has_physiologic_effect
|
What physiologic effect does {subj} have?
|
C0530105
|
cisatracurium besylate
|
C2917293
|
Neuromuscular Nondepolarizing Blockade
|
establishment of synaptic specificity at neuromuscular junction
|
Neuromuscular Nondepolarizing Blockade
|
negative regulation of synaptic transmission, GABAergic
|
Cardiac Muscle Contraction
| 1 |
C1170420::has_precise_ingredient
|
has_precise_ingredient
|
What precise ingredient does {subj} contain?
|
C1170420
|
Natelle
|
C0556150
|
docosahexaenoic acid
|
calcium carbonate / docosahexaenoate
|
cholecalciferol / docosahexaenoate / eicosapentaenoate / vitamin E
|
Docosahexaenoic acid and eicosapentaenoic acid only product
|
docosahexaenoic acid
| 3 |
C0720260::has_precise_ingredient
|
has_precise_ingredient
|
What precise ingredient does {subj} contain?
|
C0720260
|
Ergamisol
|
C0733383
|
levamisole hydrochloride
|
budipine hydrochloride
|
levamisole hydrochloride
|
amosulalol hydrochloride
|
procaterol hydrochloride
| 1 |
C0305104::has_precise_ingredient
|
has_precise_ingredient
|
What precise ingredient does {subj} contain?
|
C0305104
|
AK-Con-A
|
C0887016
|
pheniramine maleate
|
pheniramine aminosalicylate
|
triamterene / xipamide
|
pheniramine maleate
|
butaperazine maleate
| 2 |
C2207747::has_procedure_site
|
has_procedure_site
|
What is the procedure site of {subj}?
|
C2207747
|
microbiology test of right ear canal
|
C0579182
|
Inner ear and/or Eustachian canal structures
|
Inner ear and/or Eustachian canal structures
|
Left vestibulocochlear artery
|
Cochlear nucleus structure
|
Entire mucous membrane of Eustachian tube
| 0 |
C2010299::has_procedure_site
|
has_procedure_site
|
What is the procedure site of {subj}?
|
C2010299
|
gait training on dirt or uneven terrain using prosthesis for right upper extremity
|
C0230329
|
Right upper extremity
|
Lower extremity.right>Tibia
|
Left upper arm structure
|
Right upper extremity
|
Lower extremity.right>Femur
| 2 |
C0370433::has_procedure_site
|
has_procedure_site
|
What is the procedure site of {subj}?
|
C0370433
|
Excision, malignant lesion including margins, face, ears, eyelids, nose, lips; excised diameter over 4.0 cm
|
C0222110
|
Skin structure of ear
|
Skin structure of left calf
|
Structure of skin of left thigh
|
Skin structure of left shoulder
|
Skin structure of ear
| 3 |
C0448492::has_segmental_supply
|
has_segmental_supply
|
What is the segmental supply of {subj}?
|
C0448492
|
First lumbrical muscle of foot
|
C1179704
|
S1 innervation
|
S1 innervation
|
C3 branch to trapezius
|
Entire ventral lateral nucleus of thalamus
|
Pons and cerebellum, CS
| 0 |
C0224268::has_segmental_supply
|
has_segmental_supply
|
What is the segmental supply of {subj}?
|
C0224268
|
Structure of extensor digitorum muscle of hand
|
C1305861
|
C7 innervation
|
C7 level
|
C7 innervation
|
C3 branch to splenius cervicis
|
C3 branch to left trapezius
| 1 |
C0224364::has_segmental_supply
|
has_segmental_supply
|
What is the segmental supply of {subj}?
|
C0224364
|
Structure of rhomboid minor muscle
|
C1305859
|
C5 innervation
|
C3 branch to splenius cervicis
|
C3 branch to multifidus
|
C5 innervation
|
C1 branch to left splenius capitis
| 2 |
C0373665::has_specialty
|
has_specialty
|
Which specialty is associated with {subj}?
|
C0373665
|
Lactose, urine, qualitative
|
C1551301
|
Clinical Medical Laboratory
|
Expert Systems
|
Hospital-based outpatient department
|
Hospitals
|
Clinical Medical Laboratory
| 3 |
C3203353::has_specialty
|
has_specialty
|
Which specialty is associated with {subj}?
|
C3203353
|
Measurement of fibrinogen antigen
|
C1551301
|
Clinical Medical Laboratory
|
Clinical Medical Laboratory
|
Clinical Observation Units
|
Rural Health Center
|
Residential institution
| 0 |
C4521017::has_specialty
|
has_specialty
|
Which specialty is associated with {subj}?
|
C4521017
|
Serum Immunofixation Electrophoresis
|
C1551301
|
Clinical Medical Laboratory
|
Hospitals
|
Physical medicine and rehabilitation service
|
Medical intensive care unit
|
Clinical Medical Laboratory
| 3 |
C0587025::has_specimen_source_topography
|
has_specimen_source_topography
|
What is the specimen source topography of {subj}?
|
C0587025
|
Hysterectomy and unilateral salpingo-oophorectomy sample
|
C0042149
|
Uterus
|
Uterus NEC
|
Left uterine artery
|
Uterus
|
Left horn of uterus
| 2 |
C1292684::has_specimen_source_topography
|
has_specimen_source_topography
|
What is the specimen source topography of {subj}?
|
C1292684
|
Specimen from urethra
|
C0041967
|
Urethra
|
Prostatic Urethra
|
Urethra
|
Urethral vein
|
Urethralis muscle
| 1 |
C0586648::has_specimen_source_topography
|
has_specimen_source_topography
|
What is the specimen source topography of {subj}?
|
C0586648
|
Pleura biopsy specimen
|
C0032225
|
Pleura
|
Left pleural mesothelium
|
Pleura
|
Epineurium
|
Bursa specimen
| 1 |
C2725899::has_structural_class
|
has_structural_class
|
What structural class does {subj} belong to?
|
C2725899
|
white catfish allergenic extract
|
C0002092
|
Allergens
|
Drug specific allergen extract
|
Allergens
|
Allergen extract vaccine
|
Occupational allergens
| 1 |
C0006837::has_structural_class
|
has_structural_class
|
What structural class does {subj} belong to?
|
C0006837
|
Candida albicans
|
C0002092
|
Allergens
|
Allergens
|
Deer allergen
|
Occupational allergens
|
Drug specific allergen extract
| 0 |
C4519831::has_structural_class
|
has_structural_class
|
What structural class does {subj} belong to?
|
C4519831
|
Parathyroid Hormone-Related Peptide Analog
|
C0070099
|
parathyroid hormone-related protein
|
estrogen receptor beta, human
|
parathyroid hormone-related protein
|
transferrin receptor 2, human
|
Tyrosinase related protein-1
| 1 |
C2697532::has_target
|
has_target
|
What is the target of {subj}?
|
C2697532
|
HDAC/EGFR/HER2 Inhibitor CUDC-101
|
C1702024
|
ERBB2 protein, human
|
GABBR2 protein, human
|
ERBB2 protein, human
|
FCGR2B protein, human
|
NCAM2 protein, human
| 1 |
C5784712::has_target
|
has_target
|
What is the target of {subj}?
|
C5784712
|
Anti-CLDN18.2 Monoclonal Antibody ZL-1211
|
C4725710
|
Claudin-18 Isoform A2
|
Tropomyosin Alpha-3 Chain Isoform 3, human
|
Anti-PD-L1/Claudin18.2 Bispecific Antibody Q-1802
|
Anti-claudin18.2 Monoclonal Antibody AB011
|
Claudin-18 Isoform A2
| 3 |
C5783547::has_target
|
has_target
|
What is the target of {subj}?
|
C5783547
|
Anti-BTN1A1 Monoclonal Antibody hSTC810
|
C4308231
|
BTN1A1 protein, human
|
NTNG1 protein, human
|
STMN1 protein, human
|
BTN1A1 protein, human
|
ACTN1 protein, human
| 2 |
C5852778::has_technique
|
has_technique
|
What technique is used for {subj}?
|
C5852778
|
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of cecum and/or colon and/or rectum by immunohistochemistry
|
C0021044
|
Immunohistochemistry
|
Microscopic Angioscopy
|
Specular microscopy
|
indirect immunofluorescent study of IgA antibody
|
Immunohistochemistry
| 3 |
C5852777::has_technique
|
has_technique
|
What technique is used for {subj}?
|
C5852777
|
Number of tumor buds in primary malignant neoplasm of cecum and/or colon and/or rectum in microscopic field 0.785 square millimeter
|
C0430389
|
Light Microscopy
|
Light Microscopy
|
Immunoelectron microscopy study
|
Low power light microscopy
|
hairy cells by light microscopy
| 0 |
C5818634::has_technique
|
has_technique
|
What technique is used for {subj}?
|
C5818634
|
Differential count of white blood cells by manual method
|
C1441639
|
Manual count
|
Listeria culture
|
Lead measurement
|
Boron measurement
|
Manual count
| 3 |
C2351042::has_therapeutic_class
|
has_therapeutic_class
|
Which therapeutic class does {subj} belong to?
|
C2351042
|
besifloxacin
|
C4722060
|
Ophthalmic Agents [TC]
|
Cortisporin Ophthalmic
|
tropicamide ophthalmic compounding powder
|
Ophthalmic Agents [TC]
|
Antimalarial [EPC]
| 2 |
C0771341::has_therapeutic_class
|
has_therapeutic_class
|
Which therapeutic class does {subj} belong to?
|
C0771341
|
cefpirome sulfate
|
C0279516
|
Anti-Bacterial Agents
|
Macrolide Antibiotics
|
gentamicin compounding powder
|
Gramicidin- and neomycin-containing product
|
Anti-Bacterial Agents
| 3 |
C1434792::has_therapeutic_class
|
has_therapeutic_class
|
Which therapeutic class does {subj} belong to?
|
C1434792
|
ibalizumab
|
C0003451
|
Antiviral Agents
|
Tocolytic Agents
|
Antiplatelet Agents
|
Aviral
|
Antiviral Agents
| 3 |
C0030092::has_tradename
|
has_tradename
|
What is a trade name for {subj}?
|
C0030092
|
oxytetracycline
|
C0723652
|
Terramycin with Polymyxin B Sulfate
|
Polymyxin b sulfate 100% powder
|
Polymyxin-class Antibacterial [EPC]
|
Neomycin Sulfate/ Fluocinolone Acetonide
|
Terramycin with Polymyxin B Sulfate
| 3 |
C0002371::has_tradename
|
has_tradename
|
What is a trade name for {subj}?
|
C0002371
|
aluminum hydroxide
|
C0591749
|
Maalox Plus
|
Foltabs 90 Plus DHA
|
Sobrerol only product
|
Denufosol only product
|
Maalox Plus
| 3 |
C0001143::has_tradename
|
has_tradename
|
What is a trade name for {subj}?
|
C0001143
|
aclarubicin
|
C1515872
|
Aclacinon
|
Lotrimin AF
|
Brometane DX
|
pafolacianine sodium
|
Aclacinon
| 3 |
C0501289::has_tributary
|
has_tributary
|
Which of the following is a tributary of {subj}?
|
C0501289
|
Left subcostal vein
|
C0504899
|
Structure of anterior external vertebral venous plexus
|
Structure of anterior vertebral vein
|
Structure of anterior external vertebral venous plexus
|
Entire venous plexus of the hypoglossal canal
|
Structure of uterine venous plexus
| 1 |
C0004456::has_tributary
|
has_tributary
|
Which of the following is a tributary of {subj}?
|
C0004456
|
Structure of axillary vein
|
C0226801
|
Structure of basilic vein
|
Structure of glabella
|
Structure of tarsal muscle
|
Structure of pontine artery
|
Structure of basilic vein
| 3 |
C0505055::has_tributary
|
has_tributary
|
Which of the following is a tributary of {subj}?
|
C0505055
|
Left eleventh posterior thoracic radicular vein
|
C0501297
|
Medullary tributary of left eleventh posterior intercostal vein
|
Prelaminar branch of left fourth posterior intercostal artery
|
Medullary tributary of left eleventh posterior intercostal vein
|
Postcentral branch of left second posterior intercostal artery
|
Postcentral branch of left fourth posterior intercostal artery
| 1 |
C1458155::human_disease_maps_to_eo_disease
|
human_disease_maps_to_eo_disease
|
Which experimental organism disease does the human disease {subj} map to?
|
C1458155
|
Mammary Neoplasms
|
C1517920
|
LobuloAlveolar Mouse MIN
|
LobuloAlveolar Mouse MIN
|
Lethal midline granuloma stage IV
|
BAP1-inactivated melanocytoma
|
Posterior Fossa Ependymoma, Group B (PFB)
| 0 |
C0018671::human_disease_maps_to_eo_disease
|
human_disease_maps_to_eo_disease
|
Which experimental organism disease does the human disease {subj} map to?
|
C0018671
|
Head and Neck Neoplasms
|
C1514150
|
Plasmacytoma of the Mouse Pharynx
|
Plasmacytoma of the Mouse Pharynx
|
Extramedullary Plasmacytoma
|
Testicular Plasmacytoma
|
Anaplastic Pleomorphic Xanthoastrocytoma
| 0 |
C0017416::human_disease_maps_to_eo_disease
|
human_disease_maps_to_eo_disease
|
Which experimental organism disease does the human disease {subj} map to?
|
C0017416
|
Genital Neoplasms, Female
|
C1522317
|
Mouse Cervical Carcinoma
|
Cervical Squamous Cell Carcinoma
|
Mouse Cervical Carcinoma
|
Cervical Serous Adenocarcinoma
|
Metastatic Cervical Carcinoma
| 1 |
C0079829::ingredient_of
|
ingredient_of
|
Which of the following contains {subj} as an ingredient?
|
C0079829
|
methacholine chloride
|
C0703919
|
methacholine 100 mg inhalation powder for reconstitution
|
methacholine 100 mg inhalation powder for reconstitution
|
Urea[13C] 100mg powder for oral solution
|
Dextrose Monohydrate 0.245 g in 10 mL / Sodium Citrate, Unspecified Form 0.220 g in 10 mL / Citric Acid Monohydrate 0.08 g in 10 mL INTRAVENOUS SOLUTION [Anticoagulant Citrate Dextrose (ACD-A)]
|
perflubutane, phospholipid microspheres
| 0 |
C0949359::ingredient_of
|
ingredient_of
|
Which of the following contains {subj} as an ingredient?
|
C0949359
|
methotrexate sodium
|
C2242198
|
{16 (methotrexate 2.5 MG Oral Tablet) } Pack
|
{60 (doxycycline monohydrate 100 MG Oral Tablet) } Pack
|
{5 (levofloxacin 750 MG Oral Tablet) } Pack
|
{16 (methotrexate 2.5 MG Oral Tablet) } Pack
|
{28 (everolimus 5 MG Oral Tablet) } Pack
| 2 |
C0717762::ingredient_of
|
ingredient_of
|
Which of the following contains {subj} as an ingredient?
|
C0717762
|
Ethinyl Estradiol / norgestimate
|
C1877749
|
{21 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack
|
{21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Chewable Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack
|
{21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Rhuzdah 28 Day]
|
{21 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack
|
{21 (ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Chewable Tablet) / 7 (inert ingredients 1 MG Chewable Tablet) } Pack
| 2 |
C0031354::inherent_location_of
|
inherent_location_of
|
For which of the following is {subj} the inherent location?
|
C0031354
|
Pharyngeal structure
|
C5852806
|
Relative location of involved lymph nodes to primary malignant neoplasm of pharynx
|
Visceral pleura involved by direct extension of malignant neoplasm
|
Relative location of involved lymph nodes to primary malignant neoplasm of pharynx
|
Macroscopic anatomic location of primary malignant neoplasm
|
Number of lymph nodes containing isolated metastatic neoplastic cells in excised specimen
| 1 |
C5848823::inherent_location_of
|
inherent_location_of
|
For which of the following is {subj} the inherent location?
|
C5848823
|
Structure of cecum and/or colon and/or rectum
|
C5852777
|
Number of tumor buds in primary malignant neoplasm of cecum and/or colon and/or rectum in microscopic field 0.785 square millimeter
|
Presence of macroscopic perforation of small intestine by primary malignant neoplasm of small intestine
|
Number of tumor buds in primary malignant neoplasm of cecum and/or colon and/or rectum in microscopic field 0.785 square millimeter
|
Neoplasm of colon regional lymph node staging category N1c: Tumor deposit(s) in subserosa, mesentery, or nonperitonealized pericolic or perirectal tissues without regional nodal metastasis
|
Number of lymph nodes of para-aortic lymph node group containing isolated metastatic neoplastic cells in excised specimen
| 1 |
C0027763::inherent_location_of
|
inherent_location_of
|
For which of the following is {subj} the inherent location?
|
C0027763
|
Nervous system structure
|
C0036658
|
Sensory perception
|
Sensory perception
|
Melanin pigmentation
|
Nociception
|
detection of mechanical stimulus involved in sensory perception of touch
| 0 |
C0441748::inheritance_type_of
|
inheritance_type_of
|
For which genetic condition is {subj} the inheritance type?
|
C0441748
|
Autosomal recessive inheritance
|
C1832800
|
Micromelic dwarfism Fryns type
|
Micromelic dwarfism Fryns type
|
Microcephalic primordial dwarfism Dauber type
|
Macrodactyly of fingers - simple
|
Median nail dystrophy of Heller
| 0 |
C0443147::inheritance_type_of
|
inheritance_type_of
|
For which genetic condition is {subj} the inheritance type?
|
C0443147
|
Autosomal dominant inheritance
|
C1835007
|
Metachromatic Leukodystrophy, Adult-Onset, with Normal Arylsulfatase A
|
Ectodermal Dysplasia, Hypohidrotic, with Hypothyroidism and Ciliary Dyskinesia
|
Dystonia, Dopa-Responsive, With Or Without Hyperphenylalaninemia, Autosomal Recessive
|
Metachromatic Leukodystrophy, Adult-Onset, with Normal Arylsulfatase A
|
Dyskinesia, Familial, with Facial Myokymia
| 2 |
C0241764::inheritance_type_of
|
inheritance_type_of
|
For which genetic condition is {subj} the inheritance type?
|
C0241764
|
X-linked inheritance
|
C4310811
|
MEESTER-LOEYS SYNDROME
|
MEESTER-LOEYS SYNDROME
|
BECK-FAHRNER SYNDROME, AUTOSOMAL DOMINANT
|
EHLERS-DANLOS SYNDROME, NONVASCULAR VARIANT
|
STUVE-WIEDEMANN SYNDROME
| 0 |
C0199176::intent_of
|
intent_of
|
For which procedure is {subj} the intent?
|
C0199176
|
Prophylactic treatment
|
C3532848
|
Administration of prophylactic antiviral after potential sexual exposure to human immunodeficiency virus
|
Administration of second dose of pediatric hepatitis A vaccine
|
Japanese encephalitis virus vaccine, inactivated, for intramuscular use
|
Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered
|
Administration of prophylactic antiviral after potential sexual exposure to human immunodeficiency virus
| 3 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.